Severe combined immunodeficiencies (SCID)

Clinical and Experimental Immunology

Volumn 122, Issue 2, 2000, Pages 143-149

  Fischer, A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; COTRIMOXAZOLE; IMMUNOGLOBULIN; LIVE VACCINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; DISEASE COURSE; DISEASE SEVERITY; DRUG CONTRAINDICATION; ENZYME DEFECT; GENE THERAPY; HUMAN; LYMPHOCYTE COUNT; OPPORTUNISTIC INFECTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW; SUBSTITUTION THERAPY; T LYMPHOCYTE;

ADENOSINE DEAMINASE; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; FEMALE; GENE THERAPY; HUMANS; MATERNAL-FETAL EXCHANGE; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033751632     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01359.x     Document Type: Review

References (87)

1. Primary immunodeficiency diseases
2. Naturally occurring primary immunodeficiencies of the immune system
3. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 cases
4. Human severe combined immunodeficiency (SCID): Genetic, phenotypic and functional diversity in 100 infants
5. Expansion of a maternally derived monoclonal T cell population with CD3+/CD8+/T cell receptor-gamma/delta+ phenotype in a child with severe combined immunodeficiency
6. Lymphoproliferative disorders and other tumors complicating immunodeficiencies
7. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency
8. The use of T cell culture techniques to establish the presence of an intrauterine-derived maternal T cell graft in a patient with severe combined immunodeficiency (SCID)
9. Limited T cell receptor diversity of transplacentally acquired maternal T cells in severe combined immunodeficiency
10. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease
11. European experience of bone-marrow transplantation for severe combined immunodeficiency
12. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation
13. Stable engraftment of allogeneic T lymphocytes in a patient with severe combined immunodeficiency following a transfusion with unirradiated blood. Specific recognition of host histocompatibility antigens and engraftment failure of a bone marrow transplant HLA-identical to the host
14. Severe combined immunodeficiencies
15. Function of the IL2 receptor γ chain in biological responses of X-SCID B cells to IL2, IL4, IL13 and IL15
16. Non random X chromosome inactivation B cells from carriers of X chromosome severe combined immunodeficiency
17. Non random X chromosome inactivation in NK cells from carrier of X chromosome-linked severe immunodeficiency
18. Signal transduction pathway of IL-4 and IL-13 in human B cells derived from SCID-X1 patients
19. Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13
20. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans
21. The interleukin 2 receptor γ chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency SCID W1
22. IL2Rgbase: A database of gamma c-chain defects causing human X-SCID
23. Retroviral-mediated gene correlation for SCID-X1
24. Correction of IL2 receptor function in X-SCID lymphoblastoid cells by the γc gene
25. γc gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity IL2 receptor expression and function
26. Role of IL2, IL7 and IL15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from γc transduced SCID X1 bone marrow cell
27. IL2Rg gene microdeletion demonstrates that canine SCID-X1 is a homologue of the human disease
28. Lymphoid development in mice with a targeted deletion of the interleukin-2 receptor gamma chain
29. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
30. Cloning of the g chain of the human IL-2 receptor
31. The molecular basis of SCID-X1: The role of the IL2Rγ chain as a common γ chain γc
32. The interleukin receptor g chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency SCID X1
33. Multiple gamma c-dependent cytokines regulate T-cell development
34. Early lymphocyte expression is severely impaired in interleukin-7-receptor-deficient mice
35. Lymphopenia in IL7-gene-deleted mice identifies IL-7 as a non redundant cytokine
36. Common cytokine receptor γ chain (γc)-dependent cytokines understanding in vivo functions through gene targeting
37. bcl-2 Rescues T lymphopoiesis in interleukin-7 receptor-deficient mice
38. bcl-2 Can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/-mice
39. Defective IL7R expression in T- B+ NK+ severe combined immunodeficiency
40. Role of the interleukin-15 in the development of human CD56+ natural killer cells
41. Preferential utilisation of the immature JH segment and absence of somatic mutation in the CDR3 junction of the IgH chain gene in three X-linked severe combined immunodeficiency patients
42. Mutations of JAK-3 gene in patients with autosomal SCID
43. Mutation of JAK-3 in lymphoid development
44. Immunodeficiencies caused by genetic defects in protein kinases
45. Genetic study of a new-linked recessive immunodeficiency syndrome
46. A novel X-linked combined immunodeficiency disease
47. Defective human interleukin 2 receptor (IL2R) γ chain in an atypical SCIDX1 immunodeficiency with peripheral T-cells
48. Missense mutation in exon 7 of the common γc chain causes a moderate form of SCID X1
49. Interaction of the IL2Rβ and γc chain with JAK-1 and JAK-3: Implications for X SCID and X CID
50. An interleukin-2 receptor gamma chain mutation with normal thymus morphology
51. Functional role of IL-4 and IL-7 in the development of X-linked severe combined immunodeficiency
52. T lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor γ chain in a SCIDX1 patient
53. Atypical X-linked severe combined immunodeficiency due to possible spontaneous of the genetic defect in T cells
54. Diversity, functionality and stability of the T cell repertoire derived in vivo from a single human T cell precursor
55. Adenosine deaminase deficiency
56. Immunodeficiency caused by adenosine deaminase and purine nucleotide phosphorylase deficiency
57. Immunodeficiency disease caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency
58. Direct association of adenosine deaminase with a T cell activation antigen, CD26
59. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency
60. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype
61. Adult presentation of adenosine deaminase deficiency
62. Molecular basis of adenosine deaminase deficiency
63. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: Overview and case reports of three patients, including two now receiving gene therapy
64. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency
65. Successful bone-marrow transplantation for reticular dysgenesis
66. Severe combined immune deficiency presenting with cyclic hematopoiesis
67. Mutations in the tyrosine phosphatase CD45 gene in a child severe combined immunodeficiency disease
68. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice cell
69. Immunological reconstitution of sex-linked lymphopenic immunological deficiency
70. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency
71. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells
72. Severe combined immunodeficiency: Treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors
73. Thirty years of bone marrow transplantation for severe combined immunodeficiency
74. Identification of clonogenic common lymphoid progenitors on mouse bone marrow
75. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency
76. Long term immune reconstitution and out come after HLA-non identical T-cell depleted bone marrow transplantation for SCI, a European retrospective study of 116 patients
77. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: Overview and case report of three patients including two now receiving gene therapy
78. Spontaneaous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency
79. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer
80. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years
81. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase defiency
82. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates
83. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients
84. Bone marrow gene transfer in three patients with adenosine deaminase deficiency
85. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
86. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow
87. In utero transplantation of parental CD34 haematopoeitic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI)